Treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)
ABSTRACT Dopamine agonists are the first line of treatment for patients with symptomatic hyperprolactinemia due to prolactinomas and in those with idiopathic hyperprolactinemia. Treatment with these agents is effective in 80%-90% of the cases. Infertility treatment of patients with hyperprolactinemi...
Spremljeno u:
| Glavni autori: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Sociedade Brasileira de Endocrinologia e Metabologia
2024-06-01
|
| Serija: | Archives of Endocrinology and Metabolism |
| Teme: | |
| Online pristup: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972024000101001&tlng=en |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
